» Articles » PMID: 21624115

Systematic Quantitative Characterization of Cellular Responses Induced by Multiple Signals

Overview
Journal BMC Syst Biol
Publisher Biomed Central
Specialty Biology
Date 2011 Jun 1
PMID 21624115
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cells constantly sense many internal and environmental signals and respond through their complex signaling network, leading to particular biological outcomes. However, a systematic characterization and optimization of multi-signal responses remains a pressing challenge to traditional experimental approaches due to the arising complexity associated with the increasing number of signals and their intensities.

Results: We established and validated a data-driven mathematical approach to systematically characterize signal-response relationships. Our results demonstrate how mathematical learning algorithms can enable systematic characterization of multi-signal induced biological activities. The proposed approach enables identification of input combinations that can result in desired biological responses. In retrospect, the results show that, unlike a single drug, a properly chosen combination of drugs can lead to a significant difference in the responses of different cell types, increasing the differential targeting of certain combinations. The successful validation of identified combinations demonstrates the power of this approach. Moreover, the approach enables examining the efficacy of all lower order mixtures of the tested signals. The approach also enables identification of system-level signaling interactions between the applied signals. Many of the signaling interactions identified were consistent with the literature, and other unknown interactions emerged.

Conclusions: This approach can facilitate development of systems biology and optimal drug combination therapies for cancer and other diseases and for understanding key interactions within the cellular network upon treatment with multiple signals.

Citing Articles

Flash optimization of drug combinations for Acinetobacter baumannii with IDentif.AI-AMR.

You K, Binte Mohamed Yazid N, Chong L, Hooi L, Wang P, Zhuang I NPJ Antimicrob Resist. 2025; 3(1):12.

PMID: 39984645 PMC: 11845484. DOI: 10.1038/s44259-025-00079-2.


Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial.

Blasiak A, Truong A, Foo N, Tan L, Kumar K, Tan S NPJ Precis Oncol. 2025; 9(1):49.

PMID: 39984618 PMC: 11845749. DOI: 10.1038/s41698-025-00835-7.


A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AML.

Sahib N, Mohamed J, Rashid M, Jayalakshmi , Lin Y, Chee Y Cancer Med. 2024; 13(22):e70401.

PMID: 39560206 PMC: 11574777. DOI: 10.1002/cam4.70401.


Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trial.

Blasiak A, Tan L, Chong L, Tadeo X, Truong A, Senthil Kumar K NPJ Digit Med. 2024; 7(1):223.

PMID: 39191913 PMC: 11350179. DOI: 10.1038/s41746-024-01195-5.


Radiation therapy with phenotypic medicine: towards N-of-1 personalization.

Chong L, Wang P, Lee V, Vijayakumar S, Tan H, Wang F Br J Cancer. 2024; 131(1):1-10.

PMID: 38514762 PMC: 11231338. DOI: 10.1038/s41416-024-02653-3.


References
1.
Wong P, Yu F, Shahangian A, Cheng G, Sun R, Ho C . Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm. Proc Natl Acad Sci U S A. 2008; 105(13):5105-10. PMC: 2278193. DOI: 10.1073/pnas.0800823105. View

2.
Sun C, Usui T, Yu F, Al-Shyoukh I, Shamma J, Sun R . Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs. Integr Biol (Camb). 2009; 1(1):123-30. PMC: 2765122. DOI: 10.1039/b815225j. View

3.
Irish J, Hovland R, Krutzik P, Perez O, Bruserud O, Gjertsen B . Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell. 2004; 118(2):217-28. DOI: 10.1016/j.cell.2004.06.028. View

4.
Ramaswamy S . Rational design of cancer-drug combinations. N Engl J Med. 2007; 357(3):299-300. DOI: 10.1056/NEJMcibr072593. View

5.
Iadevaia S, Lu Y, Morales F, Mills G, Ram P . Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. Cancer Res. 2010; 70(17):6704-14. PMC: 2932856. DOI: 10.1158/0008-5472.CAN-10-0460. View